Andrea Necchi/LinkedIn
Feb 26, 2025, 11:10
Andrea Necchi: A Clinical Gene Therapy Study with Hematopoietic Stem Cells for the Treatment of RCC
Andrea Necchi, Head of Genitourinary Medical Oncology at Ospedale San RaffaeleOspedale, shared a post on LinkedIn:
“A Clinical Gene Therapy Study with Hematopoietic Stem Cells for the Treatment, with Single Dose of Temferon, of Patients with Metastatic Renal Cell Carcinoma (Nasdaq: GNTA) San Raffaele Telethon Institute for Gene Therapy (SR-Tiget).”
More posts featuring Andrea Necchi.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 4, 2025, 16:17
Sep 4, 2025, 16:08
Sep 4, 2025, 15:59
Sep 4, 2025, 15:51
Sep 4, 2025, 15:49
Sep 4, 2025, 15:48
Sep 4, 2025, 15:36
Sep 4, 2025, 15:34